| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |